ReviewClinical drug investigation2026
CT-P39: An Omalizumab Biosimilar.
Michael B BrownPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewClinical drug investigation2026
Michael B BrownPubMed ↗Publisher ↗
No numbers read from the abstract.